Target intelligence / Profile preview

CACNA2D1 antisense RNA 1 (CACNA2D1-AS1)

Target: CACNA2D1-AS1
Molecular classification: Long non-coding RNA, Antisense RNA

Overview

CACNA2D1 antisense RNA 1 (CACNA2D1-AS1) is presumed to be a long non-coding RNA transcribed from the antisense strand of the CACNA2D1 gene locus. There is no direct evidence in current scientific databases or literature that CACNA2D1-AS1 encodes a protein, acts as a receptor, or is targeted therapeutically. The related CACNA2D1 gene encodes a protein (alpha-2/delta-1 subunit of voltage-dependent calcium channels) known to be important in ion channel function and has been explored as a drug target[1][2][4][6][7]. No clear function, disease link, or drug interaction is documented for CACNA2D1-AS1 itself.

Other names: CACNA2D1-AS1

Biological functions

Other (likely gene regulation through antisense mechanism)

Beyond the preview

Go deeper on CACNA2D1 antisense RNA 1 (CACNA2D1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CACNA2D1 antisense RNA 1 (CACNA2D1-AS1).

Explore the full profile